Cardiovascular Sciences nets $1M in financing

TriMed Staff | | Health Imaging | Diagnostic Imaging
Cardiovascular Sciences, a technology company focused on the development of medical products, has secured a capital investment of $1 million from Seven Palm Investments.

Larry Hooper, CEO of Cardiovascular Sciences, said the Illinois-based Seven Palm may invest even more in the company.

The investment will allow the Orlando-based company to develop its products more rapidly and enter the marketplace within the next two years, Hooper said.

Cardiovascular Sciences, a client of the University of Central Florida’s (UCF) Technology Incubator, has partnered with the UCF’s department of chemistry on technology to prevent adhesions during surgery.

TriMed Staff

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.